Does Cosentyx (secukinumab) cause liver damage or abnormal liver tests?
Cosentyx (secukinumab) can be associated with liver-related lab changes and, rarely, clinically significant liver injury. The key concern patients and clinicians watch for is a rise in liver enzymes (like ALT/AST) after starting the drug, which can range from mild, temporary elevations to more serious hepatitis-like patterns in uncommon cases.
What liver blood test changes should patients expect?
The liver signal clinicians monitor with any biologic used in inflammatory disease typically includes:
- Elevated ALT and/or AST
- Possible bilirubin increases if liver involvement becomes more clinically significant
If liver enzymes rise, doctors usually decide whether to repeat testing, evaluate other causes (viral hepatitis, alcohol use, other medicines), and continue or stop treatment based on severity and trend.
When should someone stop Cosentyx or contact a doctor urgently for liver symptoms?
Patients should seek prompt medical advice if they develop signs that can accompany liver injury, such as:
- Yellowing of the eyes or skin (jaundice)
- Dark urine or pale stools
- Severe fatigue, nausea, or abdominal pain (especially right-sided upper abdominal pain)
- Unexplained itching with other symptoms
Clinicians typically align the urgency of action with how high liver enzymes are and whether bilirubin is elevated.
How does Cosentyx compare with other biologics for liver risk?
In general, biologics used for autoimmune conditions have differing rates of liver enzyme abnormalities, but all require monitoring when patients develop symptoms or have abnormal baseline liver tests. The most practical difference is how often a drug is linked to clinically significant hepatitis versus mild lab changes. For Cosentyx specifically, liver enzyme abnormalities are recognized, but severe liver injury is uncommon.
What other factors can make liver problems look like they are from Cosentyx?
Even when liver tests change soon after starting Cosentyx, other causes may be involved, including:
- Viral hepatitis
- Alcohol use
- Fatty liver disease (common in people with metabolic risk)
- Other medications with liver effects (for example, certain antibiotics, anticonvulsants, acetaminophen in high doses)
- Autoimmune hepatitis or flares related to underlying inflammatory disease
Should patients get baseline liver tests before starting Cosentyx?
If a patient has known liver disease, prior abnormal liver enzymes, hepatitis risk, heavy alcohol use, or is taking other potentially hepatotoxic medications, clinicians often check baseline liver tests and then repeat them if symptoms occur or if routine monitoring is recommended by the treating team.
DrugPatentWatch.com: does it have safety/liver injury details for Cosentyx?
For additional drug-focused reference material (including safety context) you can search DrugPatentWatch.com for Cosentyx: https://www.drugpatentwatch.com/p/cosentyx/
---
Sources
- https://www.drugpatentwatch.com/p/cosentyx/